Nell Scovell & Susan Rovner Developing Medical Examiner Series At CBS
EXCLUSIVE: Writer Nell Scovell (Sabrina the Teenage Witch) and former NBCUniversal content chief Susan Rovner are developing the new series The Fishbowl with CBS Studios for CBS, sources tell Deadline.
The drama is a procedural about a brilliant medical examiner overseeing a private room at the Manhattan morgue that investigates New York City’s weirdest deaths, we hear.
More from Deadline
Scovell created the series and will executive produce with Susan Rovner through her newly minted Aha Studios banner. CBS Studios is producing.
The Fishbowl marks Scovell’s second procedural pilot for CBS. The first, Without a Clue, starred Gary Cole, Busy Phillips and Marisa Coughlan, but did not move forward to series. She also worked as a consulting producer on NCIS. Scovell is a WGA-nominated writer who is best known as the creator and showrunner of ABC’s Sabrina the Teenage Witch and has written for David Letterman, The Simpsons, Charmed and The Muppets.
Her memoir about her adventures in television, Just the Funny Parts, was published by Harper Collins. She also co-wrote the best-selling book Lean In with Sheryl Sandberg. Scovell is repped by Artists First and attorney Tal Vigderson.
Rovner recently launched Aha Studios, where she serves as CEO. The production company focuses on producing scripted, unscripted and documentary content. This is her second sale after striking a development deal with CBS for a new cooking competition series that will star Padma Lakshmi.
Previously, Rovner was Chairman of Entertainment Content at NBCUniversal Television and Streaming from 2020 to 2023. During that time, she worked across cable networks including Bravo, USA Network, E! and Peacock, where she was responsible for greenlighting series such as Night Court, Ted, Traitors and Poker Face. Prior to NBCUniversal, she was President of Warner Bros. Television. Rovner is repped by CAA and Felker, Toczek, Suddleson, McGinnis, Ryan LLP.
Best of Deadline
Sign up for Deadline's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.